Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
29 Feb 2016
Genes Could Be the Answer to Pain Prediction
INFLUENCE of osteoarthritis genetics may be key to pain sensitivity, according to a recent study following 122 patients with knee osteoarthritis. The…
29 Feb 2016
Pain Persists in Treated Rheumatoid Arthritis Patients
NEW research has revealed that pain persists in >50% of rheumatoid arthritis (RA) patients treated with methotrexate for 3 months, even in those who…
19 Feb 2016
Introducing the European Medical Journal 1.1
United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.
24 Nov 2015
SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms
SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…
19 Nov 2015
Two New Analyses Show Cost Effectiveness of Rifaximin-α 550mg Treatment in Belgian and Dutch Patients with Recurrent Hepatic Encephalopathy
LONDON, UK, Thursday 19 November, 07.00 GMT: Norgine B.V. has presented new analyses demonstrating the cost effectiveness of XIFAXAN® / TARGAXAN® 550…
19 Oct 2015
Progress Made in New(t) Treatment for Osteoarthritis Patients
EXTRAORDINARY progress has been made towards developing effective stem cell treatment for osteoarthritis. Inspired by the ability of animals…
19 Oct 2015
Rheumatoid Arthritis Therapy Approved By NICE
BIOLOGIC monotherapy RoActemra has been issued with a positive Final Appraisal Determination by the National Institute for Health and…
28 Jul 2015
IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis
The meeting was opened by Prof Atul Deodhar who introduced the prevalence, epidemiology, and clinical features of axial spondyloarthritis (axSpA), and…
Loading posts...
« Previous
1
…
78
79
80
81
82
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View